Cancer News and Research

Latest Cancer News and Research

Researchers develop mouse model that reproduces most typical features of Noonan syndrome

Noonan syndrome is a rare disease that is characterised by a set of pathologies, including heart, facial and skeletal alterations, pulmonary stenosis, short stature, and a greater incidence of haematological problems (mainly juvenile myeloid leukaemia, or childhood leukaemia).

6 Nov 2014

M2Gen, Moffitt to serve as Central Laboratory and Biorepository for The National MDS Study

Moffitt Cancer Center and M2Gen have been awarded a contract from the National Institutes of Health's National Heart, Lung, and Blood Institute (NHLBI) to serve as the Central Laboratory and Biorepository for The National Myelodysplastic Syndromes Natural History Study (The National MDS Study).

6 Nov 2014

APHON announces recipients of 2014 APHON Membership Awards

The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.

6 Nov 2014

Eight million US women skip cervical cancer screening in the past five years

Despite evidence that cervical cancer screening saves lives, about eight million women ages 21 to 65 years have not been screened for cervical cancer in the past five years, according to a new Vital Signs report from the Centers for Disease Control and Prevention. More than half of new cervical cancer cases occur among women who have never or rarely been screened.

6 Nov 2014

Biosimilar medications could cut spending on biologics in the U.S. by $44 billion

Introducing competing "biosimilar" versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut spending on biologics in the United States by $44 billion over the next decade, according to new analysis from the RAND Corporation.

6 Nov 2014

Penn researchers show that 23% of patients who survive septic shock return to hospital within 30 days

A diagnosis of septic shock was once a near death sentence. At best, survivors suffered a substantially reduced quality of life.

6 Nov 2014

Incidence of colon and rectal cancer expected to increase by 2030 among young patients

In the next 15 years, more than one in 10 colon cancers and nearly one in four rectal cancers will be diagnosed in patients younger than the traditional screening age, according to researchers at The University of Texas MD Anderson Cancer Center.

6 Nov 2014

LA BioMed to receive Phase II funding through Grand Challenges Explorations

Los Angeles Biomedical Research Institute announced today that it will receive Phase II funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables individuals worldwide to test bold ideas to address persistent health and development challenges.

6 Nov 2014

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.

5 Nov 2014

Mortality gap persists for elderly men with severe mental disorders

The excess mortality experienced by men with severe mental disorders, compared with their mentally healthy peers, does not decrease with age, Australian research shows.

5 Nov 2014

Dr. Grace Campbell receives RNF Fellow Research Grant Award

The Rehabilitation Nursing Foundation (RNF) presents Dr. Grace Campbell, PhD BSN RN CRRN MSW, with the RNF Fellow Research Grant Award. RNF offers $30,000 in the form of multiple grants for research projects that address the clinical practice, educational or administrative dimensions of rehabilitation nursing. Dr. Campbell received her award at the ARN 40th Annual Educational Conference, October 29 - November 1, 2014 in Anaheim, CA.

5 Nov 2014

ProstaCaid dietary supplement supports prostate health

A recent presentation at an international cancer research conference in Greece reviewed the body of data on ProstaCaid, a dietary supplement compound for prostate health. A number of published studies demonstrate the formula's effects in supporting prostate health against specific prostate cancer cell lines and prostate urinary symptoms.

5 Nov 2014

UT Arlington professor uses tissue-engineered artificial lymph nodes to draw prostate cancer cells

A UT Arlington bioengineering professor is using tissue-engineered artificial lymph nodes to attract prostate cancer cells to better target and eradicate the disease.

5 Nov 2014

Light-activated diabetes drug: an interview with Dr David Hodson

We've known about chemicals that can be light-activated for about five to ten years now. They’ve mainly all been applied to neurons and, more specifically, the retina. Nobody has ever really looked at any tissues outside of the nervous system.

5 Nov 2014

New studies offer hope for breast cancer survivors struggling with cancer-related pain, swelling

Two new studies from the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania offer hope for breast cancer survivors struggling with cancer-related pain and swelling, and point to ways to enhance muscular strength and body image.

5 Nov 2014

New device facilitates diagnosis of prostate cancer

Distinguishing between benign and malignant prostate tissue is difficult. A new device facilitates the diagnosis for doctors: Through a visual analysis, they can reliably determine if they are dealing with carcinoma within a minute-and-a-half. Fraunhofer researchers will be presenting the prototype at the COMPAMED trade fair in Düsseldorf from November 12th to 14th.

5 Nov 2014

Modern bariatric surgery can cut medications in obesity patients

Patients with obesity take significantly fewer medications after weight-loss surgery than their non-surgical counterparts, and end up spending 22.4 percent less on drugs for diabetes and heart disease after four years, according to new research.

5 Nov 2014

Bluebeards Original joins with Lung Cancer Alliance to raise awareness about lung cancer

Bluebeards Original is pleased to announce that it has joined with the Lung Cancer Alliance in the month of November to help raise awareness about lung cancer and lung cancer screening. Throughout the month of November, Bluebeards Original will donate 5% of every purchase made on bluebeardsoriginal.com, while promoting lung cancer awareness on its site and through social media.

5 Nov 2014

More and more elderly people are happy to accept new foods, reveals AZTI study

Elderly people are regarded as traditional consumers, but the AZTI study reveals that there are more and more elderly people who are happy to accept new foods. However, these consumers insist that the new proposals should be similar to or evoke traditional products and flavours and, at the same time, be health-enhancing, have the right nutrient profile for their age, and be flavoursome.

5 Nov 2014

CARLINA, GenBiotech to jointly develop prolonged-release protein formulation for cartilage repair

CARLINA Technologies, a biotechnology company specialized in the development of nanomedicines, today announces the signing of a collaborative agreement with GenBiotech for the development of a prolonged-release pharmaceutical form of a protein. The resultant protein will be used in bone and cartilage repair. Financial details were not disclosed.

5 Nov 2014

Cancer News and Research

Latest Cancer News and Research

Researchers develop mouse model that reproduces most typical features of Noonan syndrome

M2Gen, Moffitt to serve as Central Laboratory and Biorepository for The National MDS Study

APHON announces recipients of 2014 APHON Membership Awards

Eight million US women skip cervical cancer screening in the past five years

Biosimilar medications could cut spending on biologics in the U.S. by $44 billion

Penn researchers show that 23% of patients who survive septic shock return to hospital within 30 days

Incidence of colon and rectal cancer expected to increase by 2030 among young patients

LA BioMed to receive Phase II funding through Grand Challenges Explorations

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

Mortality gap persists for elderly men with severe mental disorders

Dr. Grace Campbell receives RNF Fellow Research Grant Award

ProstaCaid dietary supplement supports prostate health

UT Arlington professor uses tissue-engineered artificial lymph nodes to draw prostate cancer cells

Light-activated diabetes drug: an interview with Dr David Hodson

New studies offer hope for breast cancer survivors struggling with cancer-related pain, swelling

New device facilitates diagnosis of prostate cancer

Modern bariatric surgery can cut medications in obesity patients

Bluebeards Original joins with Lung Cancer Alliance to raise awareness about lung cancer

More and more elderly people are happy to accept new foods, reveals AZTI study

CARLINA, GenBiotech to jointly develop prolonged-release protein formulation for cartilage repair

Cancer Research - Second Edition eBook

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Newsletters you may be interested in